To Investigate and characterize Neurological Immune Related Adverse Events (n-irAEs) following cancer immunotherapy as well as age and non-age-related variables impacting survival and treatment outcomes.
No takes yet. Share an insight, caveat, or question.
Pepys et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: